详情页

资源类型：

文章类型：

作者：

Shi, Yuankai[1] * ; Gui, Lin[2] ; Cheng, Ying[3] ; Wang, Huaqing[4] ; Cao, Junning[5] ; Li, Yufu[6] ; Yu, Yong[7] ; Gao, Yuhuan[8]

; Li, Zhenling[9] ; Shen, Jianzhen[10] ; Zhang, Lei[11] ; Zhang, Qingyuan[12] ; Pan, Qin[13] ; Wang, Zhen[14] ; Ke, Xiaoyan[15] ; He, Hesheng[16] ; Guo, Shuangshuang[17] ; Wang, Yihao[18] ; Xu, Xiaohong[19] ; Zou, Liqun[20] ;

机构： [1]Chinese Acad Med Sci & Peking Union Med Coll, Natl Clin Res Ctr Canc, Natl Canc Ctr, Canc Hosp,Beijing Key Lab Clin Study Anticancer M, Beijing, Peoples R China [2]Chinese Acad Med Sci & Peking Union Med Coll, Beijing Key Lab Clin Study Anticancer Mol Targe, Dept Med Oncol, Natl Canc Ctr,Natl Clin Res Ctr Canc,Canc Hosp, Beijing, Peoples R China [3]Jilin Canc Hosp, Changchun, Peoples R China [4]Nankai Univ, Tianjin Peoples Hosp, Affiliated Hosp, Tianjin, Peoples R China [5]Fudan Univ, Shanghai Canc Ctr, Shanghai, Peoples R China [6]Henan Canc Hosp, Zhengzhou, Peoples R China [7]Tianjin Med Univ Canc Inst & Hosp, Tianjin, Peoples R China [8]Hebei Med Univ, Hosp 4, Tumor Hosp Hebei Prov, Shijiazhuang, Peoples R China [9]China Japan Friendship Hosp, Dept Hematol, Beijing, Peoples R China [10]Fuijian Med Univ, Union Hosp, Fuzhou, Peoples R China [11]Zhengzhou Univ, Affiliated Hosp 1, Zhengzhou, Peoples R China [12]Harbin Med Univ, Canc Hosp, Harbin, Peoples R China [13]Zhejiang Univ, Sch Med, Dept Med Oncol, Sir Run Run Shaw Hosp, Hangzhou, Peoples R China [14]Linyi Canc Hosp, Linyi, Peoples R China [15]Peking Univ Third Hosp, Beijing, Peoples R China [16]Wannan Med Coll, Affiliated Hosp 1, Wuhu, Peoples R China [17]Henan Univ Sci & Technol, Dept Med Oncol, Affiliated Hosp 1, Luoyang, Peoples R China [18]Tianjin Med Univ, Gen Hosp, Tianjin, Peoples R China [19]Nantong Tumor Hosp, Nantong, Peoples R China [20]Sichuan Univ, West China Hosp, Chengdu, Peoples R China

出处：

ISSN：

语种：

被引次数：

WOS：

中科院分区：

出版当年[2025]版：

大类 | 1 区

医学

小类 | 1 区肿瘤学

最新[2025]版：

大类 | 1 区

医学

小类 | 1 区肿瘤学

JCR分区：

出版当年[2024]版：

Q1 ONCOLOGY

最新[2024]版：

Q1 ONCOLOGY

第一作者：

第一作者机构： [1]Chinese Acad Med Sci & Peking Union Med Coll, Natl Clin Res Ctr Canc, Natl Canc Ctr, Canc Hosp,Beijing Key Lab Clin Study Anticancer M, Beijing, Peoples R China

推荐引用方式(GB/T 7714)：

APA：

MLA：

A phase II multicenter study of abexinostat, an oral histone deacetylase inhibitor, in patients with relapsed/refractory follicular lymphoma

文献详情